Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:15 PM
Ignite Modification Date:
2026-03-26 @ 3:15 PM
NCT ID:
NCT07426666
Eligibility Criteria:
Inclusion Criteria:
* Women aged 35 to 75 years
Scheduled for elective vaginal hysterectomy for benign gynecologic indications (e.g., uterine fibroids, adenomyosis, abnormal uterine bleeding, pelvic organ prolapse)
Able to provide written informed consent
Exclusion Criteria:
Known or suspected gynecologic malignancy (endometrial, cervical, or uterine)
Allergy or hypersensitivity to local anesthetics, especially bupivacaine
Prior pelvic radiotherapy or major pelvic surgery resulting in altered anatomy
Conditions preventing vaginal cuff injection (e.g., extensive scarring, active infection)
Inability to reliably assess pain (e.g., impaired consciousness, dementia, severe psychiatric disorder)
Refusal to sign informed consent
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
35 Years
Maximum Age:
75 Years
Study:
NCT07426666
Study Brief:
Protocol Section:
NCT07426666